Recent from talks
OMICS Publishing Group
Knowledge base stats:
Talk channels stats:
Members stats:
OMICS Publishing Group
OMICS Publishing Group is a predatory publisher of open access academic journals. It started publishing its first journal in 2008. By 2015, it claimed over 700 journals, although about half of them were defunct. Its subsidiaries and brands include Allied Academies, Conference Series LLC LTD, EuroSciCon LTD, Hilaris Publishing, iMedPub LTD, International Online Medical Council (IOMC), Longdom Publishing SL, Meetings International, Prime Scholars, Pulsus Group, Research & Reviews, SciTechnol, Trade Science Inc, Life Science Events, Walsh Medical Media, and IT Medical Team.
OMICS has come under attack by numerous academics and the United States government over the validity of the peer review by OMICS journals, the appropriateness of its fees and marketing, and the apparent advertising of the names of scientists as journal editors or conference speakers without their knowledge or permission.[excessive citations] The U.S. National Institutes of Health sent a cease-and-desist letter to OMICS in 2013, demanding it to discontinue with false claims of affiliation with U.S. government entities or employees. In August 2016, OMICS became the first academic publisher to be sued by the U.S. Federal Trade Commission (FTC) for deceptive practices; nearly three years later, the FTC was awarded a summary judgement of over US$50 million.
OMICS has responded to criticisms by avowing a commitment to open access publishing, claiming that detractors are traditional subscription-based publishers who feel threatened by their open-access publishing model. It responded to the FTC suit by maintaining that their practices were legal and claiming that corporate interests were driving the suit. It has also threatened a prominent critic, Jeffrey Beall, with a $1 billion lawsuit for defamation.
OMICS Publishing Group was founded in 2007 by Gedela Srinubabu, who remains the company's director. He founded OMICS because of his difficulty in accessing high-cost journal contents as a PhD student.
It started its first open-access journal, the Journal of Proteomics & Bioinformatics, in 2008. In 2012, OMICS Group had more than 200 journal titles, about 60% of which had no content. By 2015, it claimed over 700 titles, but about half of them were defunct. Several OMICS journals have names similar to existing publications. For instance, BioMed Central established the Journal of Biomedical Science in 1994, while OMICS established the Journal of Biomedical Sciences in 2012.
OMICS employed around 2,000 people. In 2016, the company had revenue of $11.6 million and generated a profit of about $1.2 million. The Government of India has waived taxes whilst granting subsidized land for the construction of new headquarters.
OMICS operates on a gold open access model, wherein the author pays for publication and the publisher makes the articles available for free. As well as publication fees, OMICS charges a withdrawal fee for manuscripts that are withdrawn five or more days after submission. Such withdrawal fees are not levied by non-predatory publishers, and have been criticized as unethical and as discouraging researchers from making post-submission corrections to their work.
In addition to publishing journals, OMICS also organizes conferences. In 2017, about 3,000 such conferences were organized. The conference arm makes up about 60% of OMICS' revenue.
Hub AI
OMICS Publishing Group AI simulator
(@OMICS Publishing Group_simulator)
OMICS Publishing Group
OMICS Publishing Group is a predatory publisher of open access academic journals. It started publishing its first journal in 2008. By 2015, it claimed over 700 journals, although about half of them were defunct. Its subsidiaries and brands include Allied Academies, Conference Series LLC LTD, EuroSciCon LTD, Hilaris Publishing, iMedPub LTD, International Online Medical Council (IOMC), Longdom Publishing SL, Meetings International, Prime Scholars, Pulsus Group, Research & Reviews, SciTechnol, Trade Science Inc, Life Science Events, Walsh Medical Media, and IT Medical Team.
OMICS has come under attack by numerous academics and the United States government over the validity of the peer review by OMICS journals, the appropriateness of its fees and marketing, and the apparent advertising of the names of scientists as journal editors or conference speakers without their knowledge or permission.[excessive citations] The U.S. National Institutes of Health sent a cease-and-desist letter to OMICS in 2013, demanding it to discontinue with false claims of affiliation with U.S. government entities or employees. In August 2016, OMICS became the first academic publisher to be sued by the U.S. Federal Trade Commission (FTC) for deceptive practices; nearly three years later, the FTC was awarded a summary judgement of over US$50 million.
OMICS has responded to criticisms by avowing a commitment to open access publishing, claiming that detractors are traditional subscription-based publishers who feel threatened by their open-access publishing model. It responded to the FTC suit by maintaining that their practices were legal and claiming that corporate interests were driving the suit. It has also threatened a prominent critic, Jeffrey Beall, with a $1 billion lawsuit for defamation.
OMICS Publishing Group was founded in 2007 by Gedela Srinubabu, who remains the company's director. He founded OMICS because of his difficulty in accessing high-cost journal contents as a PhD student.
It started its first open-access journal, the Journal of Proteomics & Bioinformatics, in 2008. In 2012, OMICS Group had more than 200 journal titles, about 60% of which had no content. By 2015, it claimed over 700 titles, but about half of them were defunct. Several OMICS journals have names similar to existing publications. For instance, BioMed Central established the Journal of Biomedical Science in 1994, while OMICS established the Journal of Biomedical Sciences in 2012.
OMICS employed around 2,000 people. In 2016, the company had revenue of $11.6 million and generated a profit of about $1.2 million. The Government of India has waived taxes whilst granting subsidized land for the construction of new headquarters.
OMICS operates on a gold open access model, wherein the author pays for publication and the publisher makes the articles available for free. As well as publication fees, OMICS charges a withdrawal fee for manuscripts that are withdrawn five or more days after submission. Such withdrawal fees are not levied by non-predatory publishers, and have been criticized as unethical and as discouraging researchers from making post-submission corrections to their work.
In addition to publishing journals, OMICS also organizes conferences. In 2017, about 3,000 such conferences were organized. The conference arm makes up about 60% of OMICS' revenue.